National medical insurance drugs and the marketing of new drugs, which support each other, are an important guarantee for clinical patients. In recent years, a series of major reforms have been carried out in national medical insurance drugs, from the dynamic update of the list of medical insurance drugs, to the centralized procurement of drugs, the introduction of national medical insurance negotiation drugs during the agreement period, especially how innovative drugs and original drugs quickly enter the medical insurance, a series of policies and regulations have been issued. Medical students mastering the knowledge of medical insurance drugs is the basis and premise of clinical medication. Pharmacology, as the first path for school medical students to learn drugs, is the important part of cultivating the medical insurance literacy and improving the medical insurance drug audit ability of pharmacology curriculum teaching reform, and also the basis for understanding the correlation of medical insurance drugs and the marketing of new drugs.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |